We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VISN:NASDAQVistance Networks, Inc. Analysis

Data as of 2026-08-15 - not real-time

$11.53

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Vistance Networks, Inc. trades at $11.53, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Across the trailing 30 sessions it lost 6.8%. Relative strength is 46.9 — neutral — and the MACD signal is bearish. The recent range runs from support at $10.06 up to resistance at $12.52.
Multiples put this in undervalued territory: 16.6 times earnings against the sector's 36.5. Sell-side targets cluster 27.2% above the current quote.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 72.2%, a beta of 1.71 and a maximum drawdown of 51.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 4/10 long-term conviction.

Top Market Events

LVS Advisory, a New York City-based full-service investment firm, recently released its second-quarter 2026 investor...RICHARDSON, Texas, July 16, 2026--Vistance Networks NASDAQ: VISN plans to release its second quarter 2026 financial...Is VISN a good stock to buy? We came across a bullish thesis on Vistance Networks, Inc. on Valueinvestorsclub.com by...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 15.91
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 16.6 versus sector average of 36.5
  • Trading below the 200-day average of 15.91

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 16.6 versus sector average of 36.5
  • Analyst targets imply +27.2% versus the current price
  • Profit margin of 365.4% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth-1.40%
Profit Margin365.39%
P/E Ratio16.6
ROE4.31%
ROA1.35%
Debt/Equity1.57
P/B Ratio1.1
Op. Cash Flow$133.3M
Free Cash Flow$5.2M
Industry P/E36.5

Technical Analysis

TrendBearish
RSI46.9
Support$10.06
Resistance$12.52
MA 20$11.74
MA 50$12.14
MA 200$15.91
MACDBearish
VolumeIncreasing
Fear & Greed Index95.98

Valuation

Fair Value$0.61
Target Price$14.67
Upside/Downside27.20%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.71
Volatility72.23%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.